First-in-man study
phase of a clinical trial studying safety and dosage
Ratings
0
Nobody has rated this yet. Be the first!
Subject of
28
In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials
Randomized phase I clinical trial of anti-α-synuclein antibody BIIB054
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma
A phase I trial of pembrolizumab with hypofractionated radiotherapy in patients with metastatic solid tumours
Phase I/II trial of nonpegylated liposomal doxorubicin, cyclophosphamide, vincristine, and prednisone in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma
First in Man Study With SLV341
Phase I Trial of Intravenous Oncolytic Vaccinia Virus (GL-ONC1) with Cisplatin and Radiotherapy in Patients with Locoregionally Advanced Head and Neck Carcinoma
Phase I clinical trial of the CYP17 inhibitor abiraterone acetate demonstrating clinical activity in patients with castration-resistant prostate cancer who received prior ketoconazole therapy.
Safety, pharmacokinetic, pharmacodynamic, and efficacy data for the oral MEK inhibitor trametinib: a phase 1 dose-escalation trial
A phase 1 trial of preoperative partial breast radiation therapy: Patient selection, target delineation, and dose delivery
.jpg/500px-Clinical_Trial_Participant_Receives_Injection_(34033294061).jpg)